What this means
Since the advent of antiretroviral treatments, the life expectancy of people living with HIV (PLHIV) has increased significantly. In France, more than 30% of PLHIV are now over 50 years old.
A plain-English summary is on its way. Until then, this is the start of the registry's own summary.
- Status
- Recruiting
- Who can join
- Ages 75 and over
- Where
- 1 site
The science
- Registered title
- Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75
- Trial ID
- NCT07388394 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Virus-HIV
- What is tested
- interview with advanced practice nurse
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Ages
- 75 Years to no maximum
- Dates
- First posted Feb 5, 2026 · updated Oct 29, 2026
Registry summary
Since the advent of antiretroviral treatments, the life expectancy of people living with HIV (PLHIV) has increased significantly. In France, more than 30% of PLHIV are now over 50 years old. This population is exposed to high multimorbidity, leading to frequent polypharmacy, defined as the regular use of at least five medications. Polypharmacy also has a qualitative dimension, including potentially inappropriate prescriptions. It increases the risk of adverse effects and drug interactions and impairs quality of life. A coordinated geriatric approach is therefore essential to optimize care. Healthy aging, promoted by the WHO, aims to improve the lives of older people. In this context, a study will be conducted at the Nice University Hospital among PLHIV aged 75 and over. It will collect quantitative data, the results of which will enable us to consider, if necessary, adapting the care pathways of these patients whose needs are complex.
Sites (1)
- CHU de NICE, Nice, CHU de Nice, France